EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survival (Q86378721)
Jump to navigation
Jump to search
scientific article published on 11 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survival |
scientific article published on 11 March 2013 |
Statements
EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survival (English)
M Faehling
R Eckert
T Kamp
S Kuom
U Griese
J Sträter
G Ott
11 March 2013
1 reference